Photo: Igor Zarembo / RIA Novosti
In clinical trials of a vaccine developed by the National research centre of epidemiology and Microbiology named Gamalei, there are two forms of preparation: liquid and powder. Such details revealed to the press service of the Ministry, reports TASS.
Both types of drug intended for intramuscular administration. Research liquid form of the vaccine will be held in the Main military clinical hospital named after academician Burdenko, powder — in the First MSMU named after I. M. Sechenov, both institutions are located in Moscow. They will take part, two groups of volunteers for 38 people.
Previously, on 17 June it was reported that the defense Ministry of Russia jointly with the center of Gamaliel has begun clinical tests of Russian vaccine against new coronavirus infection. Main purpose of the first test — to test the safety and tolerability of the drug components. In the Burdenko hospital as the volunteers were assessed as good.
A day in Russia recorded 7843 new cases of infection with coronavirus. For the entire period of the pandemic has revealed 553 301 case of the coronavirus, died 7478 people, recovered 304 342.
Video, photo All from Russia.